nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Sorafenib—thyroid cancer	0.0508	0.331	CbGbCtD
Eszopiclone—CYP2C9—Sorafenib—thyroid cancer	0.0354	0.231	CbGbCtD
Eszopiclone—CYP3A4—Vandetanib—thyroid cancer	0.0342	0.223	CbGbCtD
Eszopiclone—CYP3A4—Sorafenib—thyroid cancer	0.0206	0.134	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—thyroid cancer	0.0125	0.0814	CbGbCtD
Eszopiclone—GABRA3—neck—thyroid cancer	0.00404	0.124	CbGeAlD
Eszopiclone—TSPO—neck—thyroid cancer	0.00278	0.0858	CbGeAlD
Eszopiclone—GABRG3—head—thyroid cancer	0.00238	0.0734	CbGeAlD
Eszopiclone—TSPO—saliva-secreting gland—thyroid cancer	0.00217	0.0669	CbGeAlD
Eszopiclone—GABRA3—thyroid gland—thyroid cancer	0.00192	0.0592	CbGeAlD
Eszopiclone—GABRA5—head—thyroid cancer	0.00183	0.0564	CbGeAlD
Eszopiclone—Dizziness—Vandetanib—thyroid cancer	0.00172	0.00212	CcSEcCtD
Eszopiclone—Vaginal infection—Epirubicin—thyroid cancer	0.00172	0.00211	CcSEcCtD
Eszopiclone—Coordination abnormal—Doxorubicin—thyroid cancer	0.00172	0.00211	CcSEcCtD
Eszopiclone—Neuropathy—Epirubicin—thyroid cancer	0.00171	0.0021	CcSEcCtD
Eszopiclone—GABRA3—head—thyroid cancer	0.0017	0.0525	CbGeAlD
Eszopiclone—Hiccups—Doxorubicin—thyroid cancer	0.00169	0.00207	CcSEcCtD
Eszopiclone—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00169	0.00207	CcSEcCtD
Eszopiclone—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00169	0.00207	CcSEcCtD
Eszopiclone—Dry eye—Epirubicin—thyroid cancer	0.00168	0.00207	CcSEcCtD
Eszopiclone—Anorexia—Sorafenib—thyroid cancer	0.00168	0.00206	CcSEcCtD
Eszopiclone—TSPO—trachea—thyroid cancer	0.00167	0.0516	CbGeAlD
Eszopiclone—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00167	0.00206	CcSEcCtD
Eszopiclone—Dermatitis contact—Doxorubicin—thyroid cancer	0.00167	0.00205	CcSEcCtD
Eszopiclone—Abnormal dreams—Doxorubicin—thyroid cancer	0.00167	0.00205	CcSEcCtD
Eszopiclone—GABRA4—head—thyroid cancer	0.00166	0.0512	CbGeAlD
Eszopiclone—Vomiting—Vandetanib—thyroid cancer	0.00166	0.00204	CcSEcCtD
Eszopiclone—Rash maculo-papular—Epirubicin—thyroid cancer	0.00166	0.00203	CcSEcCtD
Eszopiclone—Mouth ulceration—Epirubicin—thyroid cancer	0.00165	0.00202	CcSEcCtD
Eszopiclone—Bladder pain—Epirubicin—thyroid cancer	0.00165	0.00202	CcSEcCtD
Eszopiclone—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00165	0.00202	CcSEcCtD
Eszopiclone—Melaena—Doxorubicin—thyroid cancer	0.00165	0.00202	CcSEcCtD
Eszopiclone—Rash—Vandetanib—thyroid cancer	0.00164	0.00202	CcSEcCtD
Eszopiclone—Dermatitis—Vandetanib—thyroid cancer	0.00164	0.00202	CcSEcCtD
Eszopiclone—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00164	0.00201	CcSEcCtD
Eszopiclone—Headache—Vandetanib—thyroid cancer	0.00163	0.00201	CcSEcCtD
Eszopiclone—Cystitis—Doxorubicin—thyroid cancer	0.00163	0.002	CcSEcCtD
Eszopiclone—Colitis—Doxorubicin—thyroid cancer	0.00162	0.00199	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0016	0.00197	CcSEcCtD
Eszopiclone—Hypertonia—Epirubicin—thyroid cancer	0.0016	0.00196	CcSEcCtD
Eszopiclone—Vaginal infection—Doxorubicin—thyroid cancer	0.00159	0.00196	CcSEcCtD
Eszopiclone—Neuropathy—Doxorubicin—thyroid cancer	0.00158	0.00194	CcSEcCtD
Eszopiclone—Mental disability—Epirubicin—thyroid cancer	0.00158	0.00194	CcSEcCtD
Eszopiclone—Dyspnoea—Sorafenib—thyroid cancer	0.00157	0.00193	CcSEcCtD
Eszopiclone—Dry eye—Doxorubicin—thyroid cancer	0.00156	0.00191	CcSEcCtD
Eszopiclone—Lymphadenopathy—Epirubicin—thyroid cancer	0.00155	0.0019	CcSEcCtD
Eszopiclone—Nausea—Vandetanib—thyroid cancer	0.00155	0.0019	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00155	0.0019	CcSEcCtD
Eszopiclone—Dyspepsia—Sorafenib—thyroid cancer	0.00155	0.0019	CcSEcCtD
Eszopiclone—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00153	0.00188	CcSEcCtD
Eszopiclone—Decreased appetite—Sorafenib—thyroid cancer	0.00153	0.00188	CcSEcCtD
Eszopiclone—Thrombophlebitis—Epirubicin—thyroid cancer	0.00153	0.00188	CcSEcCtD
Eszopiclone—Bladder pain—Doxorubicin—thyroid cancer	0.00152	0.00187	CcSEcCtD
Eszopiclone—Mouth ulceration—Doxorubicin—thyroid cancer	0.00152	0.00187	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00152	0.00187	CcSEcCtD
Eszopiclone—Fatigue—Sorafenib—thyroid cancer	0.00152	0.00186	CcSEcCtD
Eszopiclone—Photosensitivity—Epirubicin—thyroid cancer	0.00151	0.00185	CcSEcCtD
Eszopiclone—Constipation—Sorafenib—thyroid cancer	0.0015	0.00185	CcSEcCtD
Eszopiclone—Pain—Sorafenib—thyroid cancer	0.0015	0.00185	CcSEcCtD
Eszopiclone—Hypertonia—Doxorubicin—thyroid cancer	0.00148	0.00182	CcSEcCtD
Eszopiclone—Eczema—Epirubicin—thyroid cancer	0.00147	0.00181	CcSEcCtD
Eszopiclone—Mental disability—Doxorubicin—thyroid cancer	0.00146	0.0018	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00144	0.00177	CcSEcCtD
Eszopiclone—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00143	0.00176	CcSEcCtD
Eszopiclone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00141	0.00174	CcSEcCtD
Eszopiclone—Increased appetite—Epirubicin—thyroid cancer	0.00141	0.00173	CcSEcCtD
Eszopiclone—Urticaria—Sorafenib—thyroid cancer	0.0014	0.00172	CcSEcCtD
Eszopiclone—Photosensitivity—Doxorubicin—thyroid cancer	0.00139	0.00171	CcSEcCtD
Eszopiclone—Body temperature increased—Sorafenib—thyroid cancer	0.00139	0.00171	CcSEcCtD
Eszopiclone—Abdominal pain—Sorafenib—thyroid cancer	0.00139	0.00171	CcSEcCtD
Eszopiclone—GABRG2—head—thyroid cancer	0.00139	0.0428	CbGeAlD
Eszopiclone—GABRB2—head—thyroid cancer	0.00139	0.0428	CbGeAlD
Eszopiclone—Dermatitis bullous—Epirubicin—thyroid cancer	0.00138	0.0017	CcSEcCtD
Eszopiclone—Eczema—Doxorubicin—thyroid cancer	0.00136	0.00167	CcSEcCtD
Eszopiclone—TSPO—thyroid gland—thyroid cancer	0.00132	0.0408	CbGeAlD
Eszopiclone—Diplopia—Epirubicin—thyroid cancer	0.00132	0.00163	CcSEcCtD
Eszopiclone—Osteoarthritis—Epirubicin—thyroid cancer	0.00132	0.00163	CcSEcCtD
Eszopiclone—Increased appetite—Doxorubicin—thyroid cancer	0.0013	0.0016	CcSEcCtD
Eszopiclone—Migraine—Epirubicin—thyroid cancer	0.0013	0.0016	CcSEcCtD
Eszopiclone—Affect lability—Epirubicin—thyroid cancer	0.0013	0.0016	CcSEcCtD
Eszopiclone—Hypersensitivity—Sorafenib—thyroid cancer	0.0013	0.00159	CcSEcCtD
Eszopiclone—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00128	0.00157	CcSEcCtD
Eszopiclone—Face oedema—Epirubicin—thyroid cancer	0.00128	0.00157	CcSEcCtD
Eszopiclone—GABRA2—head—thyroid cancer	0.00127	0.0391	CbGeAlD
Eszopiclone—Asthenia—Sorafenib—thyroid cancer	0.00126	0.00155	CcSEcCtD
Eszopiclone—Mood swings—Epirubicin—thyroid cancer	0.00125	0.00154	CcSEcCtD
Eszopiclone—Pruritus—Sorafenib—thyroid cancer	0.00124	0.00153	CcSEcCtD
Eszopiclone—Ataxia—Epirubicin—thyroid cancer	0.00124	0.00153	CcSEcCtD
Eszopiclone—Dehydration—Epirubicin—thyroid cancer	0.00123	0.00151	CcSEcCtD
Eszopiclone—GABRA1—head—thyroid cancer	0.00123	0.0378	CbGeAlD
Eszopiclone—Osteoarthritis—Doxorubicin—thyroid cancer	0.00122	0.0015	CcSEcCtD
Eszopiclone—Diplopia—Doxorubicin—thyroid cancer	0.00122	0.0015	CcSEcCtD
Eszopiclone—Dry skin—Epirubicin—thyroid cancer	0.00121	0.00149	CcSEcCtD
Eszopiclone—Affect lability—Doxorubicin—thyroid cancer	0.0012	0.00148	CcSEcCtD
Eszopiclone—Migraine—Doxorubicin—thyroid cancer	0.0012	0.00148	CcSEcCtD
Eszopiclone—Hypokalaemia—Epirubicin—thyroid cancer	0.0012	0.00148	CcSEcCtD
Eszopiclone—Diarrhoea—Sorafenib—thyroid cancer	0.0012	0.00148	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00119	0.00146	CcSEcCtD
Eszopiclone—Face oedema—Doxorubicin—thyroid cancer	0.00118	0.00145	CcSEcCtD
Eszopiclone—TSPO—head—thyroid cancer	0.00118	0.0362	CbGeAlD
Eszopiclone—Gastritis—Epirubicin—thyroid cancer	0.00117	0.00144	CcSEcCtD
Eszopiclone—Muscular weakness—Epirubicin—thyroid cancer	0.00117	0.00143	CcSEcCtD
Eszopiclone—Dizziness—Sorafenib—thyroid cancer	0.00116	0.00143	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—thyroid cancer	0.00116	0.00142	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—thyroid cancer	0.00115	0.00141	CcSEcCtD
Eszopiclone—Asthma—Epirubicin—thyroid cancer	0.00114	0.0014	CcSEcCtD
Eszopiclone—Dysphagia—Epirubicin—thyroid cancer	0.00114	0.0014	CcSEcCtD
Eszopiclone—Influenza—Epirubicin—thyroid cancer	0.00114	0.0014	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—thyroid cancer	0.00114	0.0014	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—thyroid cancer	0.00112	0.00138	CcSEcCtD
Eszopiclone—Vomiting—Sorafenib—thyroid cancer	0.00112	0.00137	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—thyroid cancer	0.00111	0.00137	CcSEcCtD
Eszopiclone—Rash—Sorafenib—thyroid cancer	0.00111	0.00136	CcSEcCtD
Eszopiclone—Dermatitis—Sorafenib—thyroid cancer	0.00111	0.00136	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.0011	0.00135	CcSEcCtD
Eszopiclone—Headache—Sorafenib—thyroid cancer	0.0011	0.00135	CcSEcCtD
Eszopiclone—Bronchitis—Epirubicin—thyroid cancer	0.0011	0.00135	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—thyroid cancer	0.00108	0.00133	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—thyroid cancer	0.00108	0.00133	CcSEcCtD
Eszopiclone—Dysuria—Epirubicin—thyroid cancer	0.00107	0.00131	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—thyroid cancer	0.00106	0.0013	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—thyroid cancer	0.00106	0.0013	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—thyroid cancer	0.00106	0.0013	CcSEcCtD
Eszopiclone—Pollakiuria—Epirubicin—thyroid cancer	0.00106	0.0013	CcSEcCtD
Eszopiclone—Nausea—Sorafenib—thyroid cancer	0.00105	0.00128	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00104	0.00128	CcSEcCtD
Eszopiclone—Weight increased—Epirubicin—thyroid cancer	0.00104	0.00128	CcSEcCtD
Eszopiclone—Weight decreased—Epirubicin—thyroid cancer	0.00103	0.00127	CcSEcCtD
Eszopiclone—Drowsiness—Epirubicin—thyroid cancer	0.00102	0.00125	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—thyroid cancer	0.00102	0.00125	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000999	0.00123	CcSEcCtD
Eszopiclone—Stomatitis—Epirubicin—thyroid cancer	0.000994	0.00122	CcSEcCtD
Eszopiclone—Urinary tract infection—Epirubicin—thyroid cancer	0.000991	0.00122	CcSEcCtD
Eszopiclone—Conjunctivitis—Epirubicin—thyroid cancer	0.000991	0.00122	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—thyroid cancer	0.000989	0.00122	CcSEcCtD
Eszopiclone—Sweating—Epirubicin—thyroid cancer	0.000977	0.0012	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—thyroid cancer	0.000977	0.0012	CcSEcCtD
Eszopiclone—Haematuria—Epirubicin—thyroid cancer	0.000972	0.00119	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000966	0.00119	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—thyroid cancer	0.000963	0.00118	CcSEcCtD
Eszopiclone—Epistaxis—Epirubicin—thyroid cancer	0.000962	0.00118	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—thyroid cancer	0.000957	0.00118	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—thyroid cancer	0.000943	0.00116	CcSEcCtD
Eszopiclone—PTGS1—trachea—thyroid cancer	0.000932	0.0287	CbGeAlD
Eszopiclone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000925	0.00114	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—thyroid cancer	0.000919	0.00113	CcSEcCtD
Eszopiclone—Rhinitis—Epirubicin—thyroid cancer	0.000918	0.00113	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000917	0.00113	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000917	0.00113	CcSEcCtD
Eszopiclone—Hepatitis—Epirubicin—thyroid cancer	0.000915	0.00112	CcSEcCtD
Eszopiclone—Hypoaesthesia—Epirubicin—thyroid cancer	0.000911	0.00112	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—thyroid cancer	0.000908	0.00112	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—thyroid cancer	0.000904	0.00111	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—thyroid cancer	0.000902	0.00111	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—thyroid cancer	0.000899	0.0011	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—thyroid cancer	0.00089	0.00109	CcSEcCtD
Eszopiclone—GABRA2—lymph node—thyroid cancer	0.000889	0.0274	CbGeAlD
Eszopiclone—Erythema multiforme—Epirubicin—thyroid cancer	0.000865	0.00106	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—thyroid cancer	0.000853	0.00105	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—thyroid cancer	0.000849	0.00104	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—thyroid cancer	0.000847	0.00104	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000843	0.00104	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—thyroid cancer	0.00084	0.00103	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—thyroid cancer	0.000834	0.00102	CcSEcCtD
Eszopiclone—TSPO—lymph node—thyroid cancer	0.000823	0.0254	CbGeAlD
Eszopiclone—Chills—Epirubicin—thyroid cancer	0.000821	0.00101	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—thyroid cancer	0.000809	0.000994	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000801	0.000984	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—thyroid cancer	0.00079	0.00097	CcSEcCtD
Eszopiclone—Tension—Epirubicin—thyroid cancer	0.000782	0.00096	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—thyroid cancer	0.00078	0.000958	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—thyroid cancer	0.000774	0.000951	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—thyroid cancer	0.000771	0.000947	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—thyroid cancer	0.000766	0.000941	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—thyroid cancer	0.00076	0.000933	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—thyroid cancer	0.000751	0.000922	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—thyroid cancer	0.000748	0.000919	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000739	0.000908	CcSEcCtD
Eszopiclone—PTGS1—thyroid gland—thyroid cancer	0.000737	0.0227	CbGeAlD
Eszopiclone—Anaemia—Epirubicin—thyroid cancer	0.000736	0.000905	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—thyroid cancer	0.000732	0.000899	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—thyroid cancer	0.000723	0.000889	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—thyroid cancer	0.000722	0.000887	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—thyroid cancer	0.000718	0.000883	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—thyroid cancer	0.000716	0.00088	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—thyroid cancer	0.000716	0.000879	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—thyroid cancer	0.000713	0.000876	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—thyroid cancer	0.000709	0.000871	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—thyroid cancer	0.000704	0.000865	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—thyroid cancer	0.000695	0.000853	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—thyroid cancer	0.00069	0.000848	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—thyroid cancer	0.000688	0.000845	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000684	0.00084	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—thyroid cancer	0.000681	0.000837	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—thyroid cancer	0.000678	0.000833	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—thyroid cancer	0.000678	0.000833	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—thyroid cancer	0.000677	0.000832	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—thyroid cancer	0.000676	0.00083	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—thyroid cancer	0.00067	0.000823	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—thyroid cancer	0.000665	0.000817	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—thyroid cancer	0.000663	0.000815	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—thyroid cancer	0.000662	0.000814	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—thyroid cancer	0.000656	0.000805	CcSEcCtD
Eszopiclone—PTGS1—head—thyroid cancer	0.000654	0.0202	CbGeAlD
Eszopiclone—Palpitations—Doxorubicin—thyroid cancer	0.000651	0.0008	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—thyroid cancer	0.00065	0.000799	CcSEcCtD
Eszopiclone—Infection—Epirubicin—thyroid cancer	0.000646	0.000794	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—thyroid cancer	0.000639	0.000785	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—thyroid cancer	0.000636	0.000782	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—thyroid cancer	0.000635	0.00078	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000629	0.000772	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—thyroid cancer	0.000628	0.000771	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—thyroid cancer	0.000628	0.000771	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—thyroid cancer	0.000625	0.000768	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—thyroid cancer	0.00062	0.000762	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—thyroid cancer	0.00062	0.000761	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—thyroid cancer	0.000614	0.000754	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—thyroid cancer	0.000607	0.000745	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000602	0.000739	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—thyroid cancer	0.000598	0.000734	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000592	0.000728	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—thyroid cancer	0.000588	0.000722	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—thyroid cancer	0.000587	0.000721	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—thyroid cancer	0.000584	0.000717	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000582	0.000714	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—thyroid cancer	0.00058	0.000712	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—thyroid cancer	0.000578	0.00071	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—thyroid cancer	0.000573	0.000705	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—thyroid cancer	0.000572	0.000703	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—thyroid cancer	0.000565	0.000694	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000561	0.00069	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—thyroid cancer	0.000561	0.000689	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—thyroid cancer	0.000556	0.000683	CcSEcCtD
Eszopiclone—Pain—Epirubicin—thyroid cancer	0.000556	0.000683	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000548	0.000673	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—thyroid cancer	0.000544	0.000668	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—thyroid cancer	0.00054	0.000664	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—thyroid cancer	0.000536	0.000659	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—thyroid cancer	0.000536	0.000658	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—thyroid cancer	0.000535	0.000657	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000532	0.000653	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—thyroid cancer	0.00053	0.000651	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—thyroid cancer	0.000523	0.000642	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000519	0.000638	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—thyroid cancer	0.000519	0.000637	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—thyroid cancer	0.000517	0.000635	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—thyroid cancer	0.000514	0.000632	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—thyroid cancer	0.000514	0.000632	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—thyroid cancer	0.000514	0.000631	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—thyroid cancer	0.000514	0.000631	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000496	0.000609	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000492	0.000604	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—thyroid cancer	0.000479	0.000589	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—thyroid cancer	0.000478	0.000587	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—thyroid cancer	0.000476	0.000584	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—thyroid cancer	0.000476	0.000584	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—thyroid cancer	0.000467	0.000573	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—thyroid cancer	0.00046	0.000565	CcSEcCtD
Eszopiclone—PTGS1—lymph node—thyroid cancer	0.000458	0.0141	CbGeAlD
Eszopiclone—Diarrhoea—Epirubicin—thyroid cancer	0.000445	0.000547	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000443	0.000545	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—thyroid cancer	0.000432	0.00053	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—thyroid cancer	0.00043	0.000528	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—thyroid cancer	0.000426	0.000523	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—thyroid cancer	0.000413	0.000508	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—thyroid cancer	0.000412	0.000506	CcSEcCtD
Eszopiclone—Rash—Epirubicin—thyroid cancer	0.00041	0.000504	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—thyroid cancer	0.00041	0.000503	CcSEcCtD
Eszopiclone—Headache—Epirubicin—thyroid cancer	0.000407	0.0005	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—thyroid cancer	0.000398	0.000489	CcSEcCtD
Eszopiclone—Nausea—Epirubicin—thyroid cancer	0.000386	0.000474	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—thyroid cancer	0.000383	0.00047	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—thyroid cancer	0.000379	0.000466	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—thyroid cancer	0.000379	0.000466	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—thyroid cancer	0.000377	0.000463	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—thyroid cancer	0.000357	0.000439	CcSEcCtD
